Stonepine Capital Management, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001440771

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHealth TiltHigh Turnover how tags are computed

Q3 2026 · 70 positions · Total reported value $130.24M · Top-10 concentration 58.6% · Updated 2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

Turnover: 72.7% · 16 new · 27 cut · 29 exited

Active Share (vs S&P 500): 99.9% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -2.9% · vs SPY -5.0% · Prev Value $151.28M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -4.9% · vs SPY -7.1% · Latest Value $130.24M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2026 13F filing, Stonepine Capital Management, LLC disclosed 70 equity positions with a combined reported value of $130.24M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 58.6% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2026 were VSTM ($24.49M), CAMP ($11.26M), NKTR ($6.66M). By sector, the heaviest allocations are Health Care 99.1%, Industrials 0.9%. Versus the prior quarter, allocation shifted toward Industrials (+0.7pp) and away from Health Care (-0.7pp).

Versus the prior quarter, Stonepine Capital Management, LLC opened 16 new positions, trimmed 27 and fully exited 29, a turnover rate of 72.7% of positions. The portfolio's overlap with the prior quarter was 55% of names.

The largest new positions opened in Q3 2026 were ESTA ($4.25M), MIRM ($4.20M), PYXS ($1.61M).

Of the 29 positions fully exited versus the prior quarter, the largest were MDT ($4.38M), ABT ($3.80M), BMRN ($3.12M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2026)

  • ESTA ESTABLISHMENT LABS HLDGS INC · $4.25M
  • MIRM MIRUM PHARMACEUTICALS INC · $4.20M
  • PYXS PYXIS ONCOLOGY INC · $1.61M
  • SRZN SURROZEN INC · $1.42M
  • GOSS GOSSAMER BIO INC · $747.01K
  • XENE XENON PHARMACEUTICALS INC · $743.80K
  • FEMY FEMASYS INC · $705.82K
  • AEON AEON BIOPHARMA INC · $637.72K

Fully Exited (vs previous quarter)

  • MDT MEDTRONIC PLC · prev qtr: $4.38M
  • ABT ABBOTT LABORATORIES · prev qtr: $3.80M
  • BMRN BIOMARIN PHARMACEUTICAL INC · prev qtr: $3.12M
  • XERS XERIS BIOPHARMA HOLDINGS INC · prev qtr: $2.10M
  • TELA TELA BIO INC · prev qtr: $2.00M
  • CRIS CURIS INC · prev qtr: $1.73M
  • SPRB SPRUCE BIOSCIENCES INC · prev qtr: $1.55M
  • SIBN SI BONE INC · prev qtr: $1.50M

Insider Transactions (Form 4)

Latest Stonepine Capital Management, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Stonepine Capital Management, LLC is an SEC-registered 13F filer based in Bend, OR, United States. As of Q2 2026 it reported 83 US equity positions with a combined value of $151.28M. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: BEND, OR, United States
  • SEC registration: 801-136874 (status: Approved), registered 2026-07-22
  • Regulatory AUM (Form ADV): $181.00M as of 2026-06-26
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 1 private funds, of which 1 hedge funds
  • Website: stonepinecap.com

Portfolio Structure

  • 83 positions · $151.28M reported value (Q2 2026)
  • Top 10 holdings = 44.6% of reported value
  • Largest position: VSTM (VERASTEM INC) at 8.5%
  • Average position size: $1.82M

Sector Tilt

  • Health Care 99.8%
  • Industrials 0.2%
  • Materials 0.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 23 new, 28 added, 24 reduced, 12 exited
  • 8 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 99.1%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 3.04M $24.49M 18.81%
18.81%
Reduce
2 2.79M $11.26M 8.64%
8.64%
Add
3 110.00K $6.66M 5.11%
5.11%
Reduce
4 381.98K $5.85M 4.49%
4.49%
Reduce
5 40.00K $5.60M 4.30%
4.30%
Hold
6 400.00K $5.20M 3.99%
3.99%
Reduce
7 500.00K $5.00M 3.84%
3.84%
Add
8 50.00K $4.25M 3.26%
3.26%
New
9 40.00K $4.20M 3.23%
3.23%
New
10 455.06K $3.87M 2.97%
2.97%
Reduce
11 377.43K $3.62M 2.78%
2.78%
Add
12 100.00K $3.58M 2.75%
2.75%
Hold
13 100.00K $3.00M 2.30%
2.30%
Add
14 710.27K $2.99M 2.30%
2.30%
Add
15 55.00K $2.40M 1.84%
1.84%
Add
16 964.90K $2.06M 1.58%
1.58%
Add
17 350.88K $1.87M 1.43%
1.43%
Reduce
18 189.09K $1.71M 1.31%
1.31%
Reduce
19 689.00K $1.61M 1.23%
1.23%
New
20 44.10K $1.42M 1.09%
1.09%
New
21 200.00K $1.40M 1.07%
1.07%
Reduce
22 749.03K $1.38M 1.06%
1.06%
Add
23 2.77M $1.37M 1.05%
1.05%
Add
24 188.20K $1.34M 1.03%
1.03%
Reduce
25 647.28K $1.33M 1.02%
1.02%
Add
26 100.00K $1.25M 0.96%
0.96%
Add
27 914.37K $1.18M 0.91%
0.91%
Add
28 252.43K $1.15M 0.88%
0.88%
Add
29 588.00K $1.11M 0.85%
0.85%
Reduce
30 100.00K $1.10M 0.84%
0.84%
Reduce
31 520.00K $998.40K 0.77%
0.77%
Reduce
32 676.97K $940.99K 0.72%
0.72%
Add
33 697.85K $928.14K 0.71%
0.71%
Hold
34 63.04K $747.01K 0.57%
0.57%
New
35 20.00K $743.80K 0.57%
0.57%
New
36 5.23M $719.29K 0.55%
0.55%
Reduce
37 326.77K $705.82K 0.54%
0.54%
New
38 254.76K $705.68K 0.54%
0.54%
Add
39 60.00K $702.00K 0.54%
0.54%
Add
40 95.00K $647.90K 0.50%
0.50%
Reduce
41 2.13M $637.72K 0.49%
0.49%
New
42 85.00K $628.15K 0.48%
0.48%
New
43 220.00K $598.40K 0.46%
0.46%
Add
44 233.94K $521.68K 0.40%
0.40%
Add
45 19.00K $500.41K 0.38%
0.38%
New
46 98.15K $475.03K 0.36%
0.36%
Reduce
47 787.27K $469.37K 0.36%
0.36%
Add
48 278.68K $451.46K 0.35%
0.35%
Reduce
49 414.90K $448.10K 0.34%
0.34%
Add
50 162.82K $443.68K 0.34%
0.34%
Add

Holdings Prediction Model

Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.

The next-quarter predicted Top 10 (2026-Q4) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.

Latest-Quarter Accuracy (2026-Q3)

P 70% R 70% F1 70% (modelled on 2026-Q2; 7/10 hit)

Low-confidence forecast This fund replaces about 43% of its Top-10 each quarter and backtests at F1 56% (threshold 80%). Holdings in high-turnover portfolios cannot be forecast from their own history; the figures below are illustrative.

Historical Backtest (11 quarters)

Avg precision 56% · recall 56% · F1 56% · avg rank error 3.2 · Top-10 turnover 43%

Quarter Prec. Recall F1 Predicted Top 10 Actual Top 10
2024-Q1 50% 50% 50% EOLS · ADMA · AMLX · QDEL · ALIM · XERS · LKFT · XOMA · IOBTQ · RZLT EOLS · ADMA · ALIM · LKFT · RVNC · XOMA · TELA · NKTR · MIST · SCPH
2024-Q2 70% 70% 70% EOLS · ADMA · ALIM · LKFT · RVNC · XOMA · TELA · NKTR · MIST · SCPH ADMA · ALIM · EOLS · LKFT · RVNC · XOMA · ANIK · TELA · RIGL · OPTN
2024-Q3 70% 70% 70% ALIM · ADMA · EOLS · LKFT · RVNC · XOMA · ANIK · TELA · OPTN · RIGL ADMA · EOLS · LKFT · JAZZ · RPRX · XOMA · RIGL · ZVRA · ANIK · RVNC
2024-Q4 50% 50% 50% ADMA · EOLS · LKFT · JAZZ · RPRX · ANIK · XOMA · ZVRA · IRWD · RIGL ADMA · EOLS · TELA · LKFT · ZVRA · VSTM · ACAD · OPTN · ANIK · INDV
2025-Q1 50% 50% 50% ADMA · EOLS · TELA · LKFT · ZVRA · ACAD · OPTN · VSTM · ANIK · INDV ANIP · EOLS · OPTN · ZVRA · VSTM · URGN · SRZN · ANIK · ENTA · AQST
2025-Q2 30% 30% 30% ANIP · EOLS · OPTN · ZVRA · SRZN · URGN · ENTA · VSTM · ANIK · AQST ADMA · EOLS · ZVRA · INDV · ACAD · ENTA · TELA · XOMA · ITOS · DAWN
2025-Q3 70% 70% 70% ADMA · EOLS · ZVRA · ACAD · INDV · ENTA · TELA · XOMA · ITOS · DAWN VSTM · ADMA · EOLS · ZVRA · NKTR · DAWN · XOMA · ACAD · ENTA · XFOR
2025-Q4 50% 50% 50% VSTM · ADMA · EOLS · ZVRA · DAWN · NKTR · XOMA · ACAD · XFOR · ENTA VSTM · ADMA · EOLS · ZVRA · IKT · INDV · CRBP · KZIA · XOMA · VRCA
2026-Q1 50% 50% 50% VSTM · ADMA · EOLS · IKT · ZVRA · CRBP · INDV · KZIA · XOMA · VRCA XBI · VSTM · TENX · ADMA · CAMP · NKTR · TERN · ZVRA · CRBP · KZIA
2026-Q2 50% 50% 50% XBI · VSTM · TENX · CAMP · ADMA · NKTR · TERN · ZVRA · CRBP · ANTX VSTM · TENX · NKTR · ADMA · CAMP · INSM · ELOX · KZIA · MDT · INDV
2026-Q3 ★ 70% 70% 70% VSTM · TENX · NKTR · CAMP · ADMA · ELOX · INSM · KZIA · MDT · MSLE VSTM · CAMP · NKTR · ELOX · INSM · ADMA · EOLS · ESTA · MIRM · MSLE

★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.

Barra Factor Attribution

The disclosed long US equity book from the 2026-Q3 13F is held at its report-date weights and decomposed over 2026-09-30 ~ 2026-11-13. The model uses 16 Barra style factors plus GICS sector dummies, WLS cross-sectional factor returns and an EWMA factor covariance for risk. The “portfolio” is the visible 13F book, not the fund's true NAV.

13F periodQ3 2026 Attribution quarterQ4 2026 (in progress) Window2026-09-30 → 2026-11-13 Trading days32 Holdings2 Model coverage100.0%

The quarter is not complete yet; the window ends at the latest available price date, 2026-11-13, and will update as prices arrive.

Portfolio return+5.42%Buy & hold
QQQ synthetic benchmark-13.72%Liquidity weighted
Excess return+19.14%vs benchmark
Barra annualised vol56.7%Model estimate
Realised vol44.5%Annualised in window
Weighted beta0.51Raw exposure
Factor / specific risk36% / 64%Share of variance
Top-10 concentration100.0%Of reported value
Portfolio value (start = 100)78.285.693.0100.4107.810-0110-2311-13Stonepine Capital Management, LLCQQQ syntheticLiquid universe EW
Start = 100. Red = portfolio, dark = QQQ synthetic benchmark, dashed grey = equal-weight model universe.

1. Performance

Metric Value Note
Portfolio return (buy & hold)+5.42%Disclosed long book
QQQ synthetic benchmark-13.72%Liquidity-weighted constituents
Model universe, equal weight+0.30%Opportunity-cost reference
Excess return+19.14%Portfolio − benchmark
Arithmetic return sum+6.47%Difference vs compounded is the cross term
Weighted raw beta0.51Weighted holding betas
Realised volatility (annualised)44.46%Daily returns in window
Barra model volatility (annualised)56.72%Factor + specific
Factor share of variance35.7%Barra factors
Specific share of variance64.3%Stock residuals
Reported value$8.0M13F long US equity

2. Return attribution

The +6.47% arithmetic return splits into style factors, sector factors and specific return; the table is sorted by contribution.

Factor group Factors Contribution Share of |return|
Size & Liquidity 6 -1.45% -22.5%
Momentum & Growth 3 +2.12% 32.8%
Volatility & Tail Risk 7 +7.70% 119.1%
Industry 12 +8.12% 125.6%
Specific 1 -10.02% -155.0%
Return attribution (style + industry, %)-18.8-9.4+0.0+9.4+18.8Amihud Illiquidity-0.34Growth-0.67Mid Cap+0.71Size+0.77Beta-1.75Leverage (Downside Vol)+1.90Turnover-2.36Momentum+2.50Max Drawdown+4.13Residual Volatility+5.11Skewness-7.24Health Care+8.12Historical Volatility-11.85Kurtosis+17.40
Factor Type Exposure Factor return Contribution Share of |return|
Kurtosis Style +2.49 +6.97% +17.40% 269.1%
Health Care Industry +1.00 +8.12% +8.12% 125.6%
Residual Volatility Style +1.92 +2.66% +5.11% 79.1%
Max Drawdown Style -2.11 -1.96% +4.13% 63.8%
Momentum Style -0.75 -3.34% +2.50% 38.7%
Leverage (Downside Vol) Style -1.04 -1.82% +1.90% 29.4%
Size Style -0.42 -1.83% +0.77% 11.9%
Mid Cap Style -0.42 -1.69% +0.71% 10.9%
Short-term Reversal Style +0.36 +0.79% +0.29% 4.4%
Liquidity Style -0.99 +0.22% -0.21% -3.3%
Amihud Illiquidity Style +0.83 -0.40% -0.34% -5.2%
Growth Style -0.43 +1.57% -0.67% -10.3%
Beta Style -0.36 +4.85% -1.75% -27.0%
Turnover Style +0.49 -4.77% -2.36% -36.5%
Skewness Style +1.72 -4.21% -7.24% -112.0%
Specific Specific — — -10.02% -155.0%
Historical Volatility Style +0.92 -12.86% -11.85% -183.3%

3. Risk attribution

Annualised volatility is 56.72%; factor risk explains 35.7% of variance and specific risk 64.3%. A negative variance contribution means the factor is negatively correlated with the rest of the book and acts as a partial hedge.

Risk attribution (share of variance, %)-69.5-34.7+0.0+34.7+69.5Residual Volatility-3.37Short-term Reversal-1.08Mid Cap+0.27Amihud Illiquidity+0.72Leverage (Downside Vol)+1.16Beta+1.53Liquidity+1.91Growth+2.07Kurtosis+2.62Historical Volatility+2.91Skewness+3.93Health Care+8.67Max Drawdown+14.36Specific+64.32
Factor Type Exposure Share of variance Vol contribution Share of vol
Specific Specific — 64.3% +36.48% 36.5%
Max Drawdown Style -2.11 14.4% +8.15% 8.2%
Health Care Industry +1.00 8.7% +4.92% 4.9%
Skewness Style +1.72 3.9% +2.23% 2.2%
Historical Volatility Style +0.92 2.9% +1.65% 1.6%
Kurtosis Style +2.49 2.6% +1.49% 1.5%
Growth Style -0.43 2.1% +1.18% 1.2%
Liquidity Style -0.99 1.9% +1.08% 1.1%
Beta Style -0.36 1.5% +0.87% 0.9%
Leverage (Downside Vol) Style -1.04 1.2% +0.66% 0.7%
Amihud Illiquidity Style +0.83 0.7% +0.41% 0.4%
Mid Cap Style -0.42 0.3% +0.16% 0.2%
Short-term Reversal Style +0.36 -1.1% -0.61% -0.6%
Residual Volatility Style +1.92 -3.4% -1.91% -1.9%

4. Style exposures

Standardised z-scores; positive means the book leans toward that style versus the model universe, negative means underweight.

Style exposures (z-score)-2.6-1.20.21.63.0Max DrawdownKurtosisSkewnessLeverage (Downside Vol)GrowthTurnoverAmihud IlliquidityLiquidityHistorical VolatilityResidual VolatilityShort-term ReversalMomentumBetaMid CapNon-linear SizeSizePortfolioQQQ benchmark
Style factor Portfolio QQQ benchmark Difference
Size -0.42 +2.10 -2.52
Non-linear Size -0.02 +1.68 -1.70
Mid Cap -0.42 +0.13 -0.54
Beta -0.36 +1.29 -1.66
Momentum -0.75 +0.72 -1.47
Short-term Reversal +0.36 -0.64 +1.01
Residual Volatility +1.92 -0.40 +2.32
Historical Volatility +0.92 +0.86 +0.06
Liquidity -0.99 +0.11 -1.11
Amihud Illiquidity +0.83 +1.16 -0.33
Turnover +0.49 +0.21 +0.29
Growth -0.43 +0.58 -1.01
Leverage (Downside Vol) -1.04 +0.14 -1.19
Skewness +1.72 +0.24 +1.48
Kurtosis +2.50 +0.21 +2.28
Max Drawdown -2.11 -0.08 -2.02

5. Industry allocation & Brinson

Industry allocation (weight, %)-10.020.050.080.0110.0Information TechnologyCommunication ServicesUtilitiesConsumer StaplesConsumer DiscretionaryIndustrialsHealth CarePortfolioQQQ benchmark
Sector Portfolio Benchmark Portfolio ret Benchmark ret Allocation Selection Interaction Total
Information Technology 0.0% 73.6% +0.00% -19.18% +4.32% +14.12% -14.12% +14.12%
Health Care 100.0% 1.7% +4.78% +9.16% +22.08% -0.08% -4.31% +4.62%
Communication Services 0.0% 2.6% +0.00% -15.54% +0.06% +0.41% -0.41% +0.41%
Utilities 0.0% 0.8% +0.00% +11.58% -0.20% -0.09% +0.09% -0.09%
Consumer Staples 0.0% 0.8% +0.00% +15.58% -0.24% -0.13% +0.13% -0.13%
Consumer Discretionary 0.0% 8.8% +0.00% +5.56% -1.66% -0.49% +0.49% -0.49%
Industrials 0.0% 11.1% +0.00% +7.16% -2.27% -0.80% +0.80% -0.80%
Total +21.99% +12.91% -17.29% +17.61%

6. Holdings & contribution

Symbol Name Sector Weight Return Contribution QoQ
INSM INSMED INC Health Care 69.99% +6.15% +4.30% Hold
BSX BOSTON SCIENTIFIC CORP Health Care 30.01% +1.58% +0.47% Add
Contribution rank Symbol Sector Weight Return Contribution
1 INSM Health Care 69.99% +6.15% +4.30%
2 BSX Health Care 30.01% +1.58% +0.47%

7. Conclusions

  1. Over the attribution window 2026-09-30 → 2026-11-13 (32 trading days), the reported portfolio returned +5.42%, versus -13.72% for the QQQ synthetic benchmark — an excess of +19.14%.
  2. Return attribution: the largest positive style/industry contributions came from Kurtosis +17.40%, Health Care +8.12%, Residual Volatility +5.11%; the largest drags came from Historical Volatility -11.85%, Skewness -7.24%, Turnover -2.36%. Specific (stock-level) return contributed -10.02%.
  3. Risk attribution: Barra model volatility is 56.72% annualised; factor risk explains 36% of variance and specific risk 64%. The largest factor risk sources are Max Drawdown 14.4%, Health Care 8.7%, Skewness 3.9%.
  4. Style tilt: size -0.42, momentum -0.75, volatility +0.92, liquidity -0.99; the weighted raw beta is 0.51. Positive z-scores mean the portfolio leans toward that style versus the cross-section.
  5. Industry: the largest overweight versus the benchmark is Health Care (+98.3 pp), the largest underweight is Information Technology (-73.6 pp). Allocation contributed +21.99%, selection +12.91% and interaction -17.29%.
  6. Concentration: the top-10 positions are 100.0% of the attributed portfolio and the model covers 100.0% of its value with full style exposures. This is a high-conviction, long-only 13F book — not the fund's complete NAV.
Methodology & caveats
  • 13F discloses long US equity (including some options) only; cash, shorts and non-US positions are absent. This is not the fund's true NAV.
  • Weights are the report-date reported values and stay fixed over the window (buy & hold); intra-quarter trading and flows are not captured.
  • Factor exposures are measured at quarter end and held through the next quarter; style factors are cross-sectionally orthogonalised and read as incremental exposures.
  • The database has no share-count data, so size and liquidity use dollar volume (price × volume) as a proxy; Size is closer to “traded-value scale”.
  • Factor returns come from a WLS cross-sectional regression on the model universe; risk is annualised, and some factor variance contributions can be negative.
  • 13F filings lag by up to 45 days, so the stretch from the report date to the filing date was not actionable in real time.
  • Sector mapping uses one consistent GICS level-1 scheme for both the portfolio and the benchmark.

FAQ

What did Stonepine Capital Management, LLC buy in 2026-Q3?

In its 2026-Q3 13F filing, Stonepine Capital Management, LLC reported 70 equity positions worth $130.24M in aggregate; its largest disclosed positions were VSTM ($24.49M), CAMP ($11.26M), NKTR ($6.66M).

How large is Stonepine Capital Management, LLC's portfolio?

Stonepine Capital Management, LLC reported $130.24M of long equity holdings across 70 positions as of 2026-Q3. Top-10 holdings account for 58.6% of reported value.

What is Stonepine Capital Management, LLC's investment style?

HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/stonepine-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →